BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer

Overview of attention for article published in Cancer (0008543X), April 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 51,714 followers.

Braf inhib+Mek inhib?? @yzafar: need BRAF drug #colon cancer: BRAF MT mCRC patients do worse after met resection http://t.co/VMMo31Cl0Y"

This is why we need a BRAF drug in #colorectal cancer: BRAF MT mCRC patients do worse after met resection http://t.co/7raWDavJkA #crcsm

This is why we need a BRAF drug in #colorectal cancer: BRAF MT mCRC patients do worse after met resection http://t.co/7raWDavJkA #crcsm

BRAF mutation in #colorectal #cancer confers worse prognosis even in those whom we're trying to #cure http://t.co/tXyu3GO8Jv #crcsm

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.